Imaging in Hepatocellular Carcinoma: Radiologic Assessment


Clinical Task

Radiological findings

Preprocedural assessment

(a) number and size of HCC nodules; (b) number and size of nodules considered at risk for neoplastic degeneration; (c) presence and extension of portal vein neoplastic thrombosis; (d) presence of extrahepatic tumor spread; (e) radiological signs of cirrhosis (including varices and ascites); (f) biliary dilatations; (g) radiological signs of co-morbidities

Treatment planning

(a) features of nodules such as location, degree of vascularization, and presence of pseudocapsule; (b) vascular mapping; (c) technical details of previous treatments

Evaluation of previous treatment

(a) complications; (b) tolerability and compliance; (c) radiological response




Conclusion

It has been demonstrated that radiological imaging plays a critical role in the diagnosis and management of patients with HCC. The radiological features of HCC lesions provide information that is required to determine staging and prognosis, and to select the optimal treatment protocols.




References



1.

Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30(1):61–74CrossRefPubMed


2.

Theise ND, Park YN, Kojiro M (2002) Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 6:497–512CrossRefPubMed


3.

International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 49:658–664CrossRef


4.

Bartolozzi C, Battaglia V, Bargellini I et al (2013) Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 38(2):290–296CrossRefPubMed


5.

Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104CrossRefPubMed


6.

Sangiovanni A, Manini MA, Iavarone M et al (2010) The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59(5):638–644CrossRefPubMed


7.

European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef


8.

Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRefPubMedCentralPubMed


9.

Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRefPubMedCentralPubMed


10.

Kim K, Kim CS, Han YM et al (2009) Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr 33:844–850CrossRefPubMed


11.

Leoni S, Piscaglia F, Golfieri R et al (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105(3):599–609CrossRefPubMed


12.

Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34CrossRefPubMed


13.

Roskams T (2011) Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy. Clin Liver Dis 15:245–259CrossRefPubMed


14.

Park MJ, Kim YK, Lee MH, Lee JH (2013) Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤ 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 54(2):127–136CrossRefPubMed


15.

Kim YK, Lee WJ, Park MJ et al (2012) Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology 265(1):104–114CrossRefPubMed


16.

Park MJ, Kim YK, Lee MW et al (2012) Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 264(3):761–770CrossRefPubMed


17.

Ichikawa T, Cederle MP, Grazioli L, Marsh W (2000) Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology 217:145–151CrossRefPubMed


18.

Gourtsoyianni S, Papanikolaou N, Yarmenitis S et al (2008) Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 18:486–492CrossRefPubMed


19.

Narita M, Hatano E, Arizono S et al (2009) Expression of OATP1B3 determines uptake of Gd-EOBDTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798CrossRefPubMed


20.

Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging—correlation with molecular transporters and histopathologic features. Radiology 256:817–826CrossRefPubMed


21.

Kim SH, Kim SH, Lee J et al (2009) Gadoxetic-acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681CrossRefPubMed

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Imaging in Hepatocellular Carcinoma: PET/CT
  2. Personalized Chemotherapy for Hepatocellular Carcinoma
  3. Hepatocellular Carcinoma and Patient Assessment
  4. Radiation Oncology in the Treatment of Hepatocellular Carcinoma

Stay updated, free articles. Join our Telegram channel
Tags:
Mar 26, 2017 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Imaging in Hepatocellular Carcinoma: Radiologic Assessment

Full access? Get Clinical Tree
Get Clinical Tree app for offline access